Arshad A, Arkwright P D
Child Health, University of Manchester, Manchester, UK.
J Med Ethics. 2008 May;34(5):393-5. doi: 10.1136/jme.2007.020545.
In view of the increasing complexity of research ethics committee (REC) applications and thus the time and expense involved in completing the forms, continual monitoring of outcome of clinical research studies for which ethics applications have been submitted is essential in determining whether resources are being effectively used, or alternatively whether significant numbers of research proposals are abandoned because of lack of funding or manpower. Previously published surveys for which data are available examined outcome of studies receiving REC approval 10 or more years ago.
A prospective questionnaire-based survey sent out in July 2006 to all 506 principal investigators who submitted research ethics applications to nine Greater Manchester RECs between April 2004 and March 2005. Data on the outcome of REC applications, and the status of the research study were collected and analysed.
288 of the 506 (57%) questionnaires were returned. 97% of REC applications were approved, and 87% of studies were in progress or had been completed 1-2 years after approval had been granted. Researchers employed by universities (51%), healthcare (43%) and the pharmaceutical industry (6%) had similar rates of success in initiating research studies.
This survey suggests that most research studies submitted to RECs in Manchester, UK are approved and initiated.
鉴于研究伦理委员会(REC)申请日益复杂,因而填写表格所需的时间和费用也相应增加,持续监测已提交伦理申请的临床研究结果对于确定资源是否得到有效利用,或者是否有大量研究提案因缺乏资金或人力而被放弃至关重要。此前发表的可获取数据的调查研究的是10年或更早之前获得REC批准的研究结果。
2006年7月,向在2004年4月至2005年3月期间向大曼彻斯特地区9个伦理委员会提交研究伦理申请的所有506名主要研究者发出了一份基于问卷的前瞻性调查。收集并分析了伦理申请结果及研究的状态数据。
506份问卷中有288份(57%)被收回。97%的伦理申请获得批准,87%的研究在获批后1 - 2年正在进行或已完成。受雇于大学(51%)、医疗保健机构(43%)和制药行业(6%)的研究人员在开展研究方面的成功率相近。
这项调查表明,提交给英国曼彻斯特伦理委员会的大多数研究都获得批准并得以开展。